Alignment of capsid protein VP1 sequences of all human rhinovirus prototype strains: Conserved motifs and functional domains

Journal of General Virology

Volumn 87, Issue 1, 2006, Pages 129-138

  Laine, Pia ^a   Blomqvist, Soile ^a   Savolainen, Carita ^a   Andries, Koen ^b   Hovi, Tapani ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; PROTEIN VP1; PROTEIN VP3; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CORRELATION ANALYSIS; GENETIC CONSERVATION; HUMAN RHINOVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN STRUCTURE; SENSITIVITY ANALYSIS; SEQUENCE ALIGNMENT; VIRUS MORPHOLOGY; VIRUS REPLICATION; VIRUS STRAIN;

CAPSID; CONSERVED SEQUENCE; HUMANS; PHYLOGENY; RHINOVIRUS; RNA, VIRAL; SEQUENCE ALIGNMENT; STRUCTURE-ACTIVITY RELATIONSHIP; VIRAL PROTEINS;

HUMAN RHINOVIRUS SP.; MIRIDAE;

EID: 30344470213     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.81137-0     Document Type: Article

References (55)

1. Abraham, G. & Colonno, R. J. (1984). Many rhinovirus serotypes share the same cellular receptor. J Virol 51, 340-345.
2. Airaksinen, A., Roivainen, M. & Hovi, T. (2001). Coxsackievirus A9 VP1 mutants with enhanced or hindered A particle formation and decreased infectivity. J Virol 75, 952-960.
3. Andries, K., Dewindt, B., Snoeks, J. & Willebrords, R. (1989). Lack of quantitative correlation between inhibition of replication of rhinoviruses by an antiviral drug and their stabilization. Arch Virol 106, 51-61.
4. Andries, K., Dewindt, B., Snoeks, J., Wouters, L., Moereels, H., Lewi, P. J. & Janssen, P. A. (1990). Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicity. J Virol 64, 1117-1123.
5. Arnold, E. & Rossmann, M. G. (1988). The use of molecular-replacement phases for the refinement of the human rhinovirus 14 structure. Acta Crystallogr A 44, 270-282.
6. Bella, J. & Rossmann, M. G. (1999). Review: rhinoviruses and their ICAM receptors. J Struct Biol 128, 69-74.
7. Bella, J., Kolatkar, P. R., Marlor, C. W., Greve, J. M. & Rossmann, M. G. (1998). The structure of the two amino-terminal domains of human ICAM-1 suggests how it functions as a rhinovirus receptor and as an LFA-1 integrin ligand. Proc Natl Acad Sci U S A 95, 4140-4145.
8. Blomqvist, S. (2004). Epidemiology of human rhinoviruses. PhD thesis, University of Helsinki. Publications of the National Public Health Institute, Finland, Series A (17).
9. Blomqvist, S., Savolainen, C., Råman, L., Roivainen, M. & Hovi, T. (2002). Human rhinovirus 87 and enterovirus 68 represent a unique serotype with rhinovirus and enterovirus features. J Clin Microbiol 40, 4218-4223.
10. Chapman, M. S., Minor, I., Rossmann, M. G., Diana, G. D. & Andries, K. (1991). Human rhinovirus 14 complexed with antiviral compound R 61837. J Mol Biol 217, 455-463.
11. Colonno, R. J., Condra, J. H., Mizutani, S., Callahan, P. L., Davies, M.-E. & Murcko, M. A. (1988). Evidence for the direct involvement of the rhinovirus canyon in receptor binding. Proc Natl Acad Sci U S A 85, 5449-5453.
12. Crump, C. E., Arruda, E. & Hayden, F. G. (1993). In vitro inhibitory activity of soluble ICAM-1 for the numbered serotypes of human rhinovirus. Antivir Chem Chemother 4, 323-327.
13. Davies, M., Bruce, C., Bewley, K., Outlaw, M., Mioulet, V., Lloyd, G. & Clegg, C. (2003). Poliovirus type 1 in working stocks of typed human rhinoviruses. Lancet 361, 1187-1188.
14. Fricks, C. E. & Hogle, J. M. (1990). Cell-induced conformational change in poliovirus: externalization of the amino terminus of VP1 is responsible for liposome binding. J Virol 64, 1934-1945.
15. Hadfield, A. T., Lee, W., Zhao, R., Oliveira, M. A., Minor, I., Rueckert, R. R. & Rossmann, M. G. (1997). The refined structure of human rhinovirus 16 at 2.15 Å resolution: implications for the viral life cycle. Structure 5, 427-441.
16. Hewat, E. A., Neumann, E., Conway, J. F., Moser, R., Ronacher, B., Marlovits, T. C. & Blaas, D. (2000). The cellular receptor to human rhinovirus 2 binds around the 5-fold axis and not in the canyon: a structural view. EMBO J 19, 6317-6325.
17. Hofer, F., Gruenberger, M., Kowalski, H., Machat, H., Huettinger, M., Kuechler, E. & Blaas, D. (1994). Members of the low density lipoprotein receptor family mediate cell entry of a minor-group common cold virus. Proc Natl Acad Sci U S A 91, 1839-1842.
18. Hogle, J. M., Chow, M. & Filman, D. J. (1985). Three-dimensional structure of poliovirus at 2.9 Å resolution. Science 229, 1358-1365.
19. Horsnell, C., Gama, R. E., Hughes, P. J. & Stanway, G. (1995). Molecular relationships between 21 human rhinovirus serotypes. J Gen Virol 76, 2549-2555.
20. Hovi, T. & Roivainen, M. (1993). Peptide antisera targeted to a conserved sequence in poliovirus capsid protein VP1 cross-react widely with members of the genus Enterovirus. J Clin Microbiol 31, 1083-1087.
21. Hovi, T., Airaksinen, A., Mulders, M. N. & Savolainen, C. (2000). The length of capsid protein VP1 and other variables of human enteroviruses. In XI Meeting of the European Study Group on Molecular Biology of Picornaviruses, Baia delle Zagare, Italy, abstract E12.
22. Kabsch, W. & Sander, C. (1983). Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22, 2577-2637.
23. Kim, S., Smith, T. J., Chapman, M. S., Rossmann, M. G., Pevear, D. C., Dutko, F. J., Felock, P. J., Diana, G. D. & McKinlay, M. A. (1989). Crystal structure of human rhinovirus serotype 1A (HRV1A). J Mol Biol 210, 91-111.
24. Kim, K. H., Willingmann, P., Gong, Z. X. & 10 other authors (1993). A comparison of the anti-rhinoviral drug-binding pocket in HRV14 and HRV1A. J Mol Biol 230, 206-227.
25. King, A. M. Q., Brown, F., Christian, P. & 8 other authors (2000). Picornaviridae. In Virus Taxonomy Seventh Report of the International Committee on Taxonomy of Viruses, pp. 657-678. Edited by M. H. V. van Regenmortel, C. M. Fauquet, D. H. L. Bishop, E. B. Carstens, M. K. Estes, S. M. Lemon, J. Maniloff, M. A. Mayo, D. J. McGeoch, C. R. Pringle & R. B. Wickner. San Diego: Academic Press.
26. Kolatkar, P. R., Bella, J., Olson, N. H., Bator, C. M., Baker, T. S. & Rossmann, M. G. (1999). Structural studies of two rhinovirus serotypes complexed with fragments of their cellular receptor. EMBO 118, 6249-6259.
27. Laine, P., Savolainen, C., Blomqvist, S. & Hovi, T. (2005). Phylogenetic analysis of human rhinovirus capsid protein VP1 and 2A protease coding sequences confirms shared genus-like relationships with human enteroviruses. J Gen Virol 86, 697-706.
28. Ledford, R. M., Patel, N. R., Demenczuk, T. M., Watanyar, A., Herbertz, T., Collett, M. S. & Pevear, D. C. (2004). VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds. J Virol 78, 3663-3674.
29. Lewi, P. J. (1980). Spectral map analysis. Analysis of contrasts especially from log ratios. Chemom Intell Lab Syst 5, 105-116.
30. Marlovits, T. C., Abrahamsberg, C. & Blaas, D. (1998). Very-low-density lipoprotein receptor fragment shed from HeLa cells inhibits human rhinovirus infection. J Virol 72, 10246-10250.
31. Mischak, H., Neubauer, C., Kuechler, E. & Blaas, D. (1988). Characteristics of the minor group receptor of human rhinoviruses. Virology 163, 19-25.
32. Neumann, E., Moser, R., Snyers, L., Blaas, D. & Hewat, E. A. (2003). A cellular receptor of human rhinovirus type 2, the very-low-density lipoprotein receptor, binds to two neighboring proteins of the viral capsid. J Virol 77, 8504-8511.
33. Nicholas, K. B., Nicholas, H. B., Jr & Deerfield, D. W., II (1997). GeneDoc: analysis and visualization of genetic variation. EMBNEW News 4, 14.
34. Oberste, M. S., Maher, K., Schnurr, D. & 9 other authors (2004). Enterovirus 68 is associated with respiratory illness and shares biological features with both the enteroviruses and the rhinoviruses. J Gen Virol 85, 2577-2584.
35. Olson, N. H., Kolatkar, P. R., Oliveira, M. A., Cheng, R. H., Greve, J. M., McClelland, A., Baker, T. S. & Rossmann, M. G. (1993). Structure of a human rhinovirus complexed with its receptor molecule. Proc Natl Acad Sci U S A 90, 507-511.
36. Palmenberg, A. (1989). Sequence alignments of picornaviral capsid proteins. In Molecular Aspects of Picornavirus Infection and Detection, pp. 211-241. Edited by B. L. Semler & E. Ehrenfeld. Washington, DC: American Society for Microbiology.
37. Prchla, E., Kuechler, E., Blaas, D. & Fuchs, R. (1994). Uncoating of human rhinovirus serotype 2 from late endosomes. J Virol 68, 3713-3723.
38. Roivainen, M., Piirainen, L., Närvänen, A., Rysä, T. & Hovi, T. (1993). An immunodominant N-terminal region of VP1 protein of poliovirion that is buried in crystal structure can be exposed in solution. Virology 195, 762-765.
39. Rossmann, M. G. & Palmenberg, A. C. (1988). Conservation of the putative receptor attachment site in picornaviruses. Virology 164, 373-382.
40. Rossmann, M. G., Arnold, E., Erickson, J. W. & 10 other authors (1985). Structure of a human common cold virus and functional relationship to other picornaviruses. Nature 317, 145-153.
41. Rossmann, M. G., He, Y. & Kuhn, R. J. (2002). Picornavirus-receptor interactions. Trends Microbiol 10, 324-331.
42. Rueckert, R. R. (1996). Picornaviridae: the viruses and their replication. In Fields Virology, 3rd edn, pp. 609-654. Edited by D. M. Knipe, B. N. Fields & P. E. Howley. Pennsylvania, PA: Lippincott-Raven.
43. Savolainen, C. & Hovi, T. (2003). Caveat: poliovirus may be hiding under other labels. Lancet 361, 1145-1146.
44. Savolainen, C., Blomqvist, S., Mulders, M. N. & Hovi, T. (2002). Genetic clustering of all 102 human rhinovirus prototype strains: serotype 87 is close to human enterovirus 70. J Gen Virol 83, 333-340.
45. Savolainen, C., Laine, P., Mulders, M. N. & Hovi, T. (2004). Sequence analysis of human rhinoviruses in the RNA-dependent RNA polymerase coding region reveals large within-species variation. J Gen Virol 85, 2271-2277.
46. Sherry, B. & Rueckert, R. (1985). Evidence for at least two dominant neutralization antigens on human rhinovirus 14. J Virol 53, 137-143.
47. Sherry, B., Mosser, A. G., Colonno, R. J. & Rueckert, R. R. (1986). Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14. J Virol 57, 246-257.
48. Stanway, G., Hughes, P. J., Mountford, R. C., Minor, P. D. & Almond, J. W. (1984). The complete nucleotide sequence of a common cold virus: human rhinovirus 14. Nucleic Acids Res 12, 7859-7875.
49. Thompson, J. D., Gibson, T. J., Plewniak, F., Jeanmougin, F. & Higgins, D. G. (1997). The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25, 4876-4882.
50. Uncapher, C. R., DeWitt, C. M. & Colonno, R. J. (1991). The major and minor group receptor families contain all but one human rhinovirus serotype. Virology 180, 814-817.
51. Verdaguer, N., Blaas, D. & Fita, I. (2000). Structure of human rhinovirus serotype 2 (HRV2). J Mol Biol 300, 1179-1194.
52. Verdaguer, N., Fita, I., Reithmayer, M., Moser, R. & Blaas, D. (2004). X-ray structure of a minor group human rhinovirus bound to a fragment of its cellular receptor protein. Nat Struct Mol Biol 11, 429-434.
53. Vlasak, M., Blomqvist, S., Hovi, T., Hewat, E. & Blaas, D. (2003). Sequence and structure of human rhinoviruses reveal the basis of receptor discrimination. J Virol 77, 6923-6930.
54. Vlasak, M., Roivainen, M., Reithmayer, M., Goesler, I., Laine, P., Snyers, L., Hovi, T. & Blaas, D. (2005). The minor receptor group of human rhinovirus (HRV) includes HRV23 and HRV25, but the presence of lysine in the VP1 HI loop is not sufficient for receptor binding. J Virol 79, 7389-7395.
55. Zhao, R., Pevear, D. C., Kremer, M. J., Giranda, V. L., Kofron, J. A., Kuhn, R. J. & Rossmann, M. G. (1996). Human rhinovirus 3 at 3.0 Å resolution. Structure 4, 1205-1220.